Related Experiment Videos
Lung Superimposed Pressure in Pediatric Acute Respiratory Distress Syndrome: Single-Center Study, 2014-2024
Lorenzo Ball1,2, Matilde Maxenti1, Alberto Giardina3
1Department of Surgical Sciences and Integrated Diagnostics (DISC), Università degli Studi di Genova, Genova, Italy.
Summary
Superimposed pressure (SP) in pediatric acute respiratory distress syndrome (pARDS) is lower and more variable than in adults. This pressure correlates with chest size and disease severity, not oxygenation, questioning PEEP titration strategies.
Area of Science:
- Pediatric Critical Care Medicine
- Respiratory Physiology
- Medical Imaging
Background:
- Superimposed pressure (SP) significantly impacts lung collapse in adult acute respiratory distress syndrome (ARDS).
- Understanding SP is crucial for managing positive end-expiratory pressure (PEEP) in ARDS patients.
- Limited data exists on SP in pediatric ARDS (pARDS).
Purpose of the Study:
- To characterize superimposed pressure (SP) in pediatric ARDS (pARDS).
- To investigate associations between SP and anthropometric, clinical, and quantitative CT parameters in pARDS.
- To compare SP in pARDS patients with age-matched controls.
Main Methods:
- Retrospective cohort study conducted at a tertiary care children's hospital.
- Included 12 pARDS patients and 24 age-matched controls undergoing non-contrast chest CT.
- Quantitative CT analysis measured lung aeration and SP across 10 ventral-to-dorsal regions.
Main Results:
- SP increased ventrally to dorsally in both groups but was significantly higher in pARDS patients (dorsal SP: 5.9 vs. 3.0 cm H2O).
- pARDS patients exhibited higher lung weight, lower gas/tissue ratio, and less normally aerated tissue compared to controls.
- In pARDS, SP correlated with chest circumference, lung weight, and inversely with normally aerated tissue; no association with oxygenation indices was found.
Conclusions:
- SP in pARDS is lower and more variable than in adults, influenced by disease severity and chest size.
- The lack of correlation between SP and oxygenation indices raises concerns for PEEP titration based solely on oxygenation.
- Further research is needed to validate and integrate these findings into pARDS management.
Related Concept Videos
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...